Enhancers of notch signaling and their use in the treatment of cancers and malignancies medicable by upregulation of notch

The present invention relates to the use for enhancing Notch signaling in an individual, of a compound showing the general formula (I) and/or a pharmaceutically acceptable salt or ester thereof, for the treatment of a disease selected from the group of dermatological disorders including atopic dermatitis, psoriasis, immune related disorders, cancer, squamous cell carcinoma, cutaneous and lung squamous cell carcinoma, head and neck cancer, non-melanoma skin cancer, basal cell carcinoma and actinic keratosis, neuroendocrine tumors, neuroendocrine small cell carcinoma and carcinoid tumors, thyroid carcinomas, muscular disorders muscular dystrophy and impaired regeneration capacity after injury; use in immunotherapy for cancer.


Year:
2017
Other identifiers:
EPO Family ID: 55628769
TTO: 6.1502
Patent number(s):
Laboratories:




 Record created 2017-10-01, last modified 2018-01-27


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)